MX9202512A - Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. - Google Patents
Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus.Info
- Publication number
- MX9202512A MX9202512A MX9202512A MX9202512A MX9202512A MX 9202512 A MX9202512 A MX 9202512A MX 9202512 A MX9202512 A MX 9202512A MX 9202512 A MX9202512 A MX 9202512A MX 9202512 A MX9202512 A MX 9202512A
- Authority
- MX
- Mexico
- Prior art keywords
- virus
- cultivation
- cells infected
- vaccines
- recombinant avipox
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 244000144977 poultry Species 0.000 title 1
- 241000700663 Avipoxvirus Species 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091029795 Intergenic region Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
El invento se refiere a un virus de Avipox recombinante derivado de unacapa atenuada del virus de Avipox y que comprende en una parte no esencialde su genoma al menos una secuencia de ADN que codifica la totalidad oparte de una proteína heteróloga al virus de Avipox, estando constituídala parte no esencial del genoma por una región intergénica de la TIR(región de repetición terminal inversa, en inglés " terminal invertedrepeat") Igualmente el invento se refiere al cultivo de células infectadaspor este virus, a las vacunas que contienen este virus Avipox recombinantey a la utilización de este virus como vector capaz de expresar latotalidad o parte de una proteína heteróloga al virus.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9100507A BE1004877A3 (fr) | 1991-05-27 | 1991-05-27 | Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9202512A true MX9202512A (es) | 1995-01-31 |
Family
ID=3885526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9202512A MX9202512A (es) | 1991-05-27 | 1992-05-27 | Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0517292B1 (es) |
JP (1) | JP3411307B2 (es) |
KR (1) | KR100244601B1 (es) |
CN (1) | CN1055501C (es) |
AR (1) | AR248045A1 (es) |
AT (1) | ATE189480T1 (es) |
AU (1) | AU656185B2 (es) |
BE (1) | BE1004877A3 (es) |
BR (1) | BR9202024A (es) |
CA (1) | CA2069594A1 (es) |
DE (1) | DE69230627T2 (es) |
DK (1) | DK0517292T3 (es) |
ES (1) | ES2145000T3 (es) |
HU (1) | HU215531B (es) |
IE (1) | IE921686A1 (es) |
IL (1) | IL101780A (es) |
MX (1) | MX9202512A (es) |
NZ (1) | NZ242620A (es) |
PT (1) | PT517292E (es) |
RU (1) | RU2130971C1 (es) |
SG (1) | SG49876A1 (es) |
TW (1) | TW288048B (es) |
ZA (1) | ZA923321B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0597016A4 (en) * | 1991-07-26 | 1996-04-24 | Virogenetics Corp | Infectious bursal disease virus recombinant poxvirus vaccine. |
JP3706130B2 (ja) * | 1992-01-13 | 2005-10-12 | ヴァイロジェネティクス コーポレイション | マレック病ウイルス組換えポックスウイルスワクチン |
FR2697534A1 (fr) * | 1992-11-02 | 1994-05-06 | Rhone Merieux | Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu. |
US5925358A (en) * | 1993-02-26 | 1999-07-20 | Syntro Corporation | Recombinant fowlpox viruses and uses thereof |
CA2156423A1 (en) * | 1993-02-26 | 1994-09-01 | Mark D. Cochran | Recombinant fowlpox viruses and uses thereof |
US6136318A (en) * | 1993-02-26 | 2000-10-24 | Cochran; Mark D. | Recombinant fowlpox viruses and uses thereof |
FR2728794B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro |
FR2728795B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
GB9711957D0 (en) | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
GB0118532D0 (en) | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
EP1450854A2 (en) | 2001-11-30 | 2004-09-01 | Isis Innovation Limited | Vaccine |
GB2382578A (en) * | 2001-11-30 | 2003-06-04 | Isis Innovation | Fowlpox-based vaccine |
NZ536502A (en) * | 2002-05-16 | 2005-10-28 | Bavarian Nordic As | Recombinant poxvirus expressing homologous genes inserted into the poxviral genome for inducing an immune response in a mammal |
WO2005048957A2 (en) * | 2003-02-20 | 2005-06-02 | Therion Biologics Corporation | Novel insertion sites in pox vectors |
GB2402391A (en) * | 2003-06-04 | 2004-12-08 | Oxxon Pharmaccines Ltd | Fowlpox recombinant genome |
PE20141482A1 (es) | 2011-11-30 | 2014-11-08 | Merial Ltd | Vectores recombinantes de hvt que expresan antigenos de patogenos de aves y sus usos |
EP2845904A1 (en) | 2013-09-06 | 2015-03-11 | Ceva Sante Animale | Recombinant Marek's disease viruses and uses thereof |
EP3050572A1 (en) | 2015-01-29 | 2016-08-03 | Ceva Sante Animale | Recombinant MDV1 and the uses thereof |
EP3263129A1 (en) | 2016-06-29 | 2018-01-03 | Ceva Sante Animale | Duck enteritis virus and the uses thereof |
KR102617503B1 (ko) | 2016-12-14 | 2023-12-29 | 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 | 조류 병원체의 다중 항원을 발현하는 재조합 hvt 벡터 및 그를 포함하는 백신 |
CN113347992A (zh) | 2018-12-27 | 2021-09-03 | 法国诗华大药厂 | 重组病毒和其用途 |
MA58717A1 (fr) | 2020-06-17 | 2023-06-28 | Boehringer Ingelheim Vetmedica Gmbh | Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988002022A1 (en) * | 1986-09-22 | 1988-03-24 | Commonwealth Scientific And Industrial Research Or | Recombinant poxviruses |
FR2632863B2 (fr) * | 1987-10-29 | 1990-08-31 | Transgene Sa | Virus du fowlpox recombinant et vaccins derives de ces virus |
JP2538367B2 (ja) * | 1988-06-24 | 1996-09-25 | ブリティッシュ・テクノロジー・グループ・リミテッド | Fowlpoxウィルスの非必須領域 |
EP0419666A4 (en) * | 1988-12-29 | 1991-05-15 | Nippon Zeon Co., Ltd. | Promoter, plasmid containing the same, and recombinant avipoxvirus |
AU643216B2 (en) * | 1989-05-30 | 1993-11-11 | Commonwealth Scientific And Industrial Research Organisation | Production of IBDV VP2 in highly immunogenic form |
-
1991
- 1991-05-27 BE BE9100507A patent/BE1004877A3/fr not_active Expired - Lifetime
-
1992
- 1992-03-19 SG SG9608014A patent/SG49876A1/en unknown
- 1992-05-05 IL IL10178092A patent/IL101780A/xx active IP Right Grant
- 1992-05-06 NZ NZ242620A patent/NZ242620A/xx unknown
- 1992-05-06 TW TW081103546A patent/TW288048B/zh active
- 1992-05-07 ZA ZA923321A patent/ZA923321B/xx unknown
- 1992-05-18 AU AU16323/92A patent/AU656185B2/en not_active Ceased
- 1992-05-19 EP EP92201406A patent/EP0517292B1/fr not_active Expired - Lifetime
- 1992-05-19 AT AT92201406T patent/ATE189480T1/de not_active IP Right Cessation
- 1992-05-19 DK DK92201406T patent/DK0517292T3/da active
- 1992-05-19 ES ES92201406T patent/ES2145000T3/es not_active Expired - Lifetime
- 1992-05-19 DE DE69230627T patent/DE69230627T2/de not_active Expired - Fee Related
- 1992-05-19 PT PT92201406T patent/PT517292E/pt unknown
- 1992-05-26 HU HU9201746A patent/HU215531B/hu not_active IP Right Cessation
- 1992-05-26 CA CA002069594A patent/CA2069594A1/fr not_active Abandoned
- 1992-05-26 AR AR92322400A patent/AR248045A1/es active
- 1992-05-27 RU SU5052222A patent/RU2130971C1/ru active
- 1992-05-27 KR KR1019920009005A patent/KR100244601B1/ko not_active IP Right Cessation
- 1992-05-27 JP JP13533192A patent/JP3411307B2/ja not_active Expired - Fee Related
- 1992-05-27 CN CN92105030A patent/CN1055501C/zh not_active Expired - Fee Related
- 1992-05-27 BR BR929202024A patent/BR9202024A/pt not_active Application Discontinuation
- 1992-05-27 MX MX9202512A patent/MX9202512A/es unknown
- 1992-07-01 IE IE168692A patent/IE921686A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1632392A (en) | 1992-12-03 |
SG49876A1 (en) | 2002-04-16 |
CN1069068A (zh) | 1993-02-17 |
EP0517292B1 (fr) | 2000-02-02 |
JP3411307B2 (ja) | 2003-05-26 |
IL101780A (en) | 2000-12-06 |
BE1004877A3 (fr) | 1993-02-16 |
EP0517292A1 (fr) | 1992-12-09 |
KR920021706A (ko) | 1992-12-18 |
HU215531B (hu) | 2000-05-28 |
KR100244601B1 (ko) | 2000-03-02 |
AR248045A1 (es) | 1995-05-31 |
HUT62331A (en) | 1993-04-28 |
TW288048B (es) | 1996-10-11 |
CA2069594A1 (fr) | 1992-11-28 |
HU9201746D0 (en) | 1992-08-28 |
ATE189480T1 (de) | 2000-02-15 |
BR9202024A (pt) | 1993-01-19 |
JPH05244939A (ja) | 1993-09-24 |
NZ242620A (en) | 1993-09-27 |
IE921686A1 (en) | 1992-12-02 |
IL101780A0 (en) | 1992-12-30 |
CN1055501C (zh) | 2000-08-16 |
DK0517292T3 (da) | 2000-05-08 |
RU2130971C1 (ru) | 1999-05-27 |
DE69230627T2 (de) | 2000-09-28 |
AU656185B2 (en) | 1995-01-27 |
DE69230627D1 (de) | 2000-03-09 |
PT517292E (pt) | 2000-06-30 |
ES2145000T3 (es) | 2000-07-01 |
ZA923321B (en) | 1993-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9202512A (es) | Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. | |
ES2061708T3 (es) | Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus. | |
ES2664505T3 (es) | Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas | |
ATE420190T1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
ES2140418T3 (es) | Flavivirus quimericos y/o flavivirus de crecimiento restringido. | |
AR003425A1 (es) | Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv) | |
DE69232393D1 (de) | Rekombinierte virale nukleinsäure aus pflanzen | |
DE69434820D1 (de) | Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis | |
SG55095A1 (en) | Viruses and their use as a vaccine against feline infectious peritonitis virus disease | |
KR930701610A (ko) | 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학분야에서 이들을 사용하는 방법 | |
ATE294857T1 (de) | Impfstoff gegen infektionen mit lentiviren, wie dem felinen immunschwäche-virus der katze | |
DK0831899T3 (da) | Rekombinant koppevirus-calicivirus-præparater og anvendelser | |
DK0651806T3 (da) | Vacciner imod katteimmundeficiensvirus (FIV) | |
ES2062990T3 (es) | Vacunas, que contienen la proteina f del virus del sida. | |
IL146191A0 (en) | Viral expression vectors | |
ATE237629T1 (de) | Rekombinanter virus der marek-krankheit, verfahren zur herstellung dieses viruses und diesen enthaltender impfstoff | |
AU686000B2 (en) | Infectious peritonitis vaccine | |
DE3789545T2 (de) | Impfstoff bestehend aus einem Virusvektor und Rekombinanten-DNS, die das p25-Protein vom AIDS-Virus kodieren. | |
BR9801992A (pt) | Processos para a preparação de vìrus da doença de marek usando linhas celulares contìnuas de mamìfero. | |
WO1992014818A3 (en) | Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences | |
TH33841A (th) | รีคอมบิแนนท์เอวิพอคซ์ไวรัส การเพาะเลี้ยงเซลล์ที่ติดเชื้อไวรัสนี้ และวัคซีนสำหรับสัตว์ปีกที่อนุพัทธ์จากไวรัสนี้ | |
TH22679B (th) | การเอ็กซ์เพรสโพลีเพพไทด์ของไวรัสก่อโรคทางระบบหายใจที่แพร่พันธุ์ได้ในสุกรในเซลล์เดียวกัน | |
TH33841EX (th) | รีคอมบิแนนท์เอวิพอคซ์ไวรัส การเพาะเลี้ยงเซลล์ที่ติดเชื้อไวรัสนี้ และวัคซีนสำหรับสัตว์ปีกที่อนุพัทธ์จากไวรัสนี้ |